What workup and management are indicated for a patient presenting with hair loss, fatigue, arthralgia, bone pain, and headache?

Workup and Management for Hair Loss, Fatigue, Joint/Bone Pain, and Headache

This constellation of symptoms—hair loss, fatigue, arthralgia, bone pain, and headache—should prompt immediate evaluation for endocrine disorders, particularly thyroid dysfunction and hypophysitis, with thyroid function tests (TSH, free T4) being the most critical initial laboratory investigation.

Initial Diagnostic Approach

Priority Laboratory Testing

The workup should begin with targeted laboratory evaluation based on the symptom cluster:

Essential first-line tests:

• Thyroid function: TSH and free T4 (morning testing preferred around 8 am) 1
• Complete metabolic panel: Calcium, phosphate, creatinine, alkaline phosphatase 2, 3
• Adrenal function: ACTH and cortisol (or 1 mcg cosyntropin stimulation test if hypophysitis suspected) 1
• Inflammatory markers: ESR/CRP to evaluate for systemic inflammatory conditions
• Nutritional assessment: Serum ferritin, 25-hydroxyvitamin D, vitamin B12 4, 5

Additional testing based on clinical context:

• Parathyroid hormone (PTH) if calcium/phosphate abnormalities present 2, 3
• Gonadal hormones (testosterone in men, estradiol in women), FSH, LH if pituitary dysfunction suspected 1
• Thyroid peroxidase (TPO) antibody if hypothyroidism confirmed 1

Critical Clinical Distinctions

Hypothyroidism pattern: If presenting with fatigue, weight gain, hair loss, cold intolerance, and constipation with elevated TSH and low free T4, this indicates primary hypothyroidism requiring thyroid hormone replacement 1, 6.

Hypophysitis pattern: If showing low TSH with low free T4 (suggesting central etiology) combined with headache and fatigue, this raises concern for hypophysitis and requires MRI of the sella with pituitary cuts prior to steroid administration 1. Hypophysitis typically presents 8-9 weeks after immune checkpoint inhibitor exposure with headache (85% of cases) and fatigue (66% of cases).

X-linked hypophosphatemia (XLH) pattern: If bone pain, fatigue, and headaches are prominent with evidence of low serum phosphorus and elevated alkaline phosphatase, consider XLH, particularly if there is history of skeletal deformities or dental abscesses 2, 3, 7.

Management Algorithm

For Confirmed Hypothyroidism

Initiate levothyroxine replacement therapy with standard dosing based on weight and age 1, 6.

Critical safety consideration: If both adrenal insufficiency and hypothyroidism are present, always start steroids before thyroid hormone to avoid precipitating adrenal crisis 1.

For Suspected Hypophysitis

1. Obtain MRI before starting steroids to document pituitary abnormalities 1
2. Replace deficient hormones with physiologic doses of steroids and thyroid hormone 1
3. Use high-dose steroids only for severe headaches, vision changes, or adrenal crisis 1
4. Counsel patients that hormonal replacement is typically lifelong 1
5. All patients with adrenal insufficiency must obtain and carry a medical alert bracelet 1

For Hair Loss Management

If nutritional deficiencies identified:

• Supplement ferritin if levels are low (mean levels in hair loss patients: 14.72 ng/mL vs 25.30 ng/mL in controls) 5
• Supplement vitamin D if deficient (79.6% of hair loss patients have low vitamin D) 5

If hair loss persists despite treating underlying conditions:

• Topical minoxidil 5% foam or solution is first-line treatment, applied twice daily for optimal results 4, 8, 9
• Consider low-dose oral minoxidil (LDOM) if topical therapy fails: start women at 1.25 mg daily (or 0.5 mg if low weight/baseline low BP), men at 2.5 mg daily 8, 9
• Monitor blood pressure and pulse before and 2 hours after first LDOM dose 9

For Bone Pain and Metabolic Bone Disease

If XLH or other metabolic bone disease confirmed:

• Burosumab is superior to conventional therapy (oral phosphate plus active vitamin D) for rickets healing and symptom improvement in children 7
• Adults with symptomatic disease require treatment with either burosumab or conventional therapy (active vitamin D with or without phosphate salts) 3
• Never use phosphate salts as monotherapy 3
• Monitor serum phosphorus, calcium, alkaline phosphatase, PTH, and vitamin D levels regularly 2, 3, 7

Common Pitfalls to Avoid

1. Do not start thyroid hormone before steroids in patients with combined adrenal insufficiency and hypothyroidism—this can trigger life-threatening adrenal crisis 1

2. Do not administer steroids before obtaining MRI in suspected hypophysitis—this can obscure diagnostic findings 1

3. Do not assume hair loss is purely dermatologic—it may be the presenting sign of systemic endocrine or metabolic disease 1, 4

4. Do not overlook vitamin D and ferritin deficiency—these are present in the majority of patients with diffuse hair loss and should be corrected before other hair loss treatments 5

5. Do not prescribe LDOM without baseline cardiovascular assessment—particularly in women with low body weight or baseline hypotension who may experience significant BP drops even at 0.25-0.5 mg doses 8, 9

Follow-Up Monitoring

• Repeat thyroid function tests 6-8 weeks after initiating or adjusting thyroid hormone replacement 6
• Monitor for resolution of symptoms, particularly fatigue and hair regrowth (expect minimum 3-6 months for hair regrowth) 10, 8
• Reassess nutritional markers (ferritin, vitamin D) after 3 months of supplementation 5
• For metabolic bone disease, monitor biochemical markers every 3-6 months initially 3, 7